Bruno Lunenfeld

Bruno Lunenfeld is Professor Emeritus at the Faculty of Life Sciences, Bar-Ilan University, and Ramat Gan, Israel. He is General Secretary of The Asian-Pacific Initiative on Reproductive Endocrinology. He is President of the International Society for the Study of the Aging Male, and Editor of The Aging Male, a journal devoted to men’s health and aging.
He graduated from the medical School in Geneva Switzerland. Following his post graduate work in Geneva he joined the Weitzman Institute as senior Scientist 1959 -1962, and from 1962-1995 was chairman of the Institute of Endocrinology, Chaim Sheba Medical Center and the WHO International Reference Center for Fertility Promoting Drugs. From 1984-1986 was Acting Chief Scientist Ministry of Health. He acted as a Consultant and member of Expert Committees at the World Health Organization for more than 25 years.
Professor Lunenfeld is best known for his pioneering work in humanreproduction. After describing the clinical use of hMG in men and women in 1960, his group was the first to achieve a pregnancy with hMG in 1961, demonstrated binding of hCG to LH receptors in theca cells in 1967 and were the first to induce ovulation followed by pregnancy with GnRH in an hMG-stimulated cycle in 1975. His research interests pertain to the physiology and pathology of male and female reproduction. These include stimulators, modulators and regulators of, spermatogenesis, spermiogenesis, folliculogenesis and ovulation,. His present research involves the mechanism of action of gonadotrophins, Kisspeptides, GnRH and growth factors on gene expression and steroidogenesis
At his initiative in1997 at the Royal Society of Medicine in London ISSAM was registered with the objective of promoting research , study and education on all matters relating to men health. The main goal of ISSAM was to allow men and women to age in health and dignity
He organized in collaboration with the World Health Organization the first, second and third world Congress of the aging male in Geneva ,and co- organized 11more such congresses.The last in 2014 year in Almaty (Khazastan).
He organized 9 symposia on GnRH analogues in cancer and reproduction, published more than 400 papers 19 books including a textbook on Male and Female Infertility and one of the “first textbooks on Men’s Health. He gave more than 700 invited lectures and chaired or co-chaired more than 300 sessions at national/international Meetings. He trained more than 200 local and foreign physicians and supervised more than 50 MD, MSC, and Ph.D. Students
Professor Lunenfeld has received several distinguished international awards for his scientific achievements, including the special recognition award of the United States Public Health Service for his outstanding contribution in the promotion of health from the Surgeon General (1983), the Verdienstkreuz 1 Klasse – one of Germany’s highest honours – signed by the President of Germany, Roman Herzog (1995), the Bertarelli Foundation Award for his lifetime achievements in women’s health (2002) and the World Fertility Awareness Month Lifetime Achievement Award (2005).
Professor Lunenfeld is honorary member of European Society of Human Reproduction and Embryology( ESHRE), the International Federation of Fertility Societies (IFFS), German, Polish and Italian. Swiss Society of Gynecology and Obstetrics, German Endocrine Society of Reproduction, Austrian Society of Fertility and Sterility, and the Asian Society of Andrology.

Acino

Acino Rus – Russian subsidiary of the international pharmaceutical group Acino headquartered in Zurich, Switzerland – markets high quality Rx and OTC products throughout Russia making them accessible for our clients and partners, patients and health facilities.

NORWEGIAN Fish Oil

NORWEGIAN Fish Oil is one of the best manufacturers of high quality and safe fish products. A highly specialized company, a recognized expert in its field. The headquarters is located in Trondheim (Norway). The production is located in Scandinavia in cutting-edge pharmaceutical plants (GMP, ISO 9001, 9002, HASSP, etc.). Products are presented in 50 countries of the world.

Svetlana Kalinchenko

Svetlana Yurievna Kalinchenko graduated with honors from the Faculty of scientific and scientific-pedagogical cadres of the MMA named after I.M.Sechenov (first graduation). Among the best students, she completed an internship at University clinics in Germany and Spain. At the institute, she delved into the issue of the influence of sex hormones on the somatic and mental state of a person. She was repeatedly awarded as the best young scientist. A year after graduation, the first scientific articles were published, and in 1998, under the guidance of Professor G.I. Kozlov, defended her Ph.D. thesis on “Hormonal treatment of male transsexualism and its side effects”.

While studying in residency at the Endocrinological Research Center PAMH (ESC PAMH), she specialized in sexology with the founder of Soviet sexology and sexopathology, Professor G.S. Vasilchenko, which influenced the choice of the topic for further scientific research.

In 1993, together with Professor G.I. Kozlov organized the first group of therapeutic andrology in Russia, which she later headed. In 2003, the andrology group was separated into the department of andrology and urology as part of the reproduction department of the ESC PAMH.

Since 1998, one of the first in the country and the world has begun to develop the topic of prevention and treatment of aging in men. In 2006 he defended his doctoral dissertation on the topic “Age-related androgenic deficiency. Clinic. Diagnostics. Treatment”. In 2006, in collaboration with Academician I.I. Dedov publishes the monograph “Age-related androgenic deficiency in men”, which opened a new era in medicine – the era of hormone replacement therapy in men, including men with benign prostatic hyperplasia. S.Yu. Kalinchenko advocates an innovative approach to the cardiovascular and hormonal safety of androgen therapy.

To prove the metabolic safety of androgen therapy, S.Yu. Kalinchenko initiated and received in 2005 permission from the Ministry of Health of the Russian Federation to conduct a double-blind, placebo-controlled study with a prolonged testosterone preparation, which was later called the Moscow Study. The results of this research are presented in the Ph.D. thesis by Yu.A. Tishova “The role of hypogonadism correction in the treatment of metabolic syndrome in men” (2009), performed under the guidance of S.Yu. Kalinchenko. The results of this study are referenced by world scientists, as well as by the US FDA. In this work, for the first time in the world, the possibility of eliminating both obesity and metabolic syndrome, as well as type 2 diabetes mellitus in men, was shown against the background of hypogonadism compensation.

In addition, S.Yu. Kalinchenko. has repeatedly acted as the principal investigator in the III phase of clinical trials: “Proteostasis and erectile dysfunction. A drug with a stimulating effect on sexual activity “; “Metabolic syndrome in men. The androgenic drug “; “Energy, sexual status and body proportions in men. The androgenic drug “; “Osteoporosis in hypogonadal men. The drug is an inhibitor of bone resorption “; “Diabetes mellitus in men. PDE-5 inhibitor “.

S.Yu. Kalinchenko is one of the world’s leading experts in the treatment of erectile dysfunction. The work of S.Yu. Kalinchenko “Restoration of sexual function after oral administration of testosterone to men with diabetes mellitus resistant to sildenafil citrate” marked the beginning of a new approach to the treatment of erectile dysfunction – a combination therapy with androgens and phosphodiesterase type 5 inhibitors, which supplanted the surgical treatment of erectile dysfunction.

S.Yu. Kalinchenko in 2008 organizes a thematic improvement course on the topic “Endocrine Aspects of Reproductive Health” at the Faculty of Advanced Training of Medical Workers at the RUDN University, and then, in 2009, the Department of Endocrinology, starting in 2020, the Department of Endocrinology with a course of holistic medicine, at the same faculty. Professor S.Yu. Kalinchenko develops the ideas of an interdisciplinary and holistic approach, both in the prevention and treatment of age-associated diseases. At the Department of Endocrinology, headed by S.Yu. Kalinchenko, laid the foundation for a new direction in the medicine of androgen therapy for women, and developed a new model of medicine – “Medicine 5P”, based on the patented author’s methodology “Quartet of health”. Thanks to the works of S.Yu. Kalinchenko and her students, in 2016 androgen therapy for women began to be used along with traditional methods of menopausal hormone therapy, which was reflected in the recommendations from 2016 of the International Menopause Society (IMS).

Under the guidance of S.Yu. Kalinchenko defended 9 candidate dissertations, currently, 3 doctoral and 3 candidate dissertations are being carried out.

S.Yu. Kalinchenko is a recognized leader in the diagnosis, prevention, and treatment of a pandemic of the XXI century – vitamin D deficiency. In 2011, S.Yu. Kalinchenko has developed a unique approach to the prevention and treatment of age-related diseases, which consists of complex therapy aimed at eliminating insulin resistance and oxidative stress.

Has a total of more than 350 publications, of which more than 10 educational and methodological and more than 10 scientific works are used in teaching practice.

The Hirsch index according to the RSCI (for the entire period of scientific activity) – 18. The works of Svetlana Yurievna were cited more than 3000 times.

Is an:

  • Member of the Andropause Society;
  • Member of EUA (European Society of Urology);
  • Member of the Scientific Committee of the European Society for the Study of Aging in Men;
  • And also a member of the American Society of Endocrinologists.

S.Yu. Kalinchenko is Vice President of the International Society for the Study of Aging Men (ISSAM). Since 2011, she has taken part in 20 international and 25 all-Russian conferences, including the Chairperson of the VII and IX International conferences of ISSAM.

Laureate of the All-Russian competition “Reproductive Tomorrow of Russia” (2015) in the nomination “Vocation – Doctor”, for the promotion of hormonal health among doctors. Kalinchenko S.Yu. is the editor-in-chief of the journal “Questions of Dietetics”.

She completed an internship as a visiting specialist at the Department of Andrology at Karolinska University (Stockholm, Sweden).

Dr Adrian Heald

Dr Adrian Heald is a Consultant Physician in the NHS in the UK. He is a Research Fellow and Lecturer at Manchester University and Visiting Tutor at St. Peters College, Oxford.  

Adrian obtained his Medicine degree from St Peter’s College, Oxford and trained at the John Radcliffe Hospital, Oxford. He then moved to Manchester, where he qualified in Psychiatry, before returning to work in general medicine, specializing in diabetes / endocrinology. Adrian is a member of the Royal College of Psychiatrists and the Royal College of Physicians, and was awarded a DM Thesis by Oxford University in 2005. 

With an area of research that is predominantly focused on the impact of insulin resistance and the insulin-like growth factor system on diabetes and coronary disease risk, Adrian has published numerous peer reviewed papers on topics relating to this area. This now also includes work on the impact of epigenetics on CVD risk in insulin resistance and type 2 diabetes. Particular current focus areas of his work are looking at population genetics in relation to risks of developing complications in type 2 diabetes and in the impact of hypogonadism on men’s health and life expectancy. 

MyGenetics

MyGenetics is a high-tech company that conducts DNA analysis in the field of nutrition, cosmetics and sports. We have been working since 2013 to change people’s lives to better by losing weight efficiently, chosing the right sport and cosmetics to understand their body and develop their innate portential.

Deer Pharm

DEERPHARM is a family antler farm in the heart of the Oleniy Nature Park. 

DEERPHARM is a new generation of adaptogens. 

* sources of macro and microelements for normalization of metabolic processes – dietary supplement pantogematogen C (additional source of iron) and dietary supplement antler powder dirpant (additional source of calcium and phosphorus) 

* a source of glucosamine and chondroitin for the full functioning of the spine, joints and cartilage – antler slices 

 * balneo product – antler baths 

International Society for Studying of the Aging Male (UK)

The International Society for the Study of the Aging Male (ISSAM) was formed and incorporated in the United Kingdom in 1997 with the objective of promoting research, study and education on all matters relating to men’s health after the age of 30.
The Society aims to encourage physicians and other health-care professionals to understand male illness in the context of the aging process as a whole and to adopt a multi-disciplinary approach to caring for male patients. More specifically, the Society sets out to promote the concept of healthy aging.